Market Closed

EDIT
Editas Medicine
$ 2.17
1.40%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Editas Medicine News

Latest Editas Medicine Stock News & EDIT Headlines

Editas Medicine (EDIT) Reports Q3 Loss, Tops Revenue Estimates
6 days ago | zacks.com
Editas Medicine Announces Third Quarter 2026 Results and Business Updates
6 days ago | globenewswire.com
Editas Medicine (NASDAQ:EDIT) Stock Breaks Below 50 Day Moving Average – Here’s Why
a month ago | defenseworld.net
Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference
a month ago | globenewswire.com
EDIT Set to Begin First-in-Human Study in Hypercholesterolemia
a month ago | zacks.com
Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia
a month ago | globenewswire.com
Editas Medicine (NASDAQ:EDIT) Stock Breaks Below 50-Day Moving Average – Here’s Why
a month ago | defenseworld.net
Bank of New York Mellon Corp Invests $851,000 in Editas Medicine, Inc. $EDIT
2 months ago | defenseworld.net
Editas Medicine Reports Inducement Grants to New Chief Medical Officer
2 months ago | globenewswire.com
Editas Medicine Eyes First Human Trial for CRISPR Cholesterol Therapy EDIT-401
2 months ago | marketbeat.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

EDIT
Editas Medicine
$ 2.17
1.40%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago